Want to see AU:IDT full AI Analyst Report?
IDT Stock Chart & Stats
AU$0.05
>-AU$0.01(-1.87%)
At close: 4:00 PM EST
AU$0.05
>-AU$0.01(-1.87%)
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.07
Previous CloseN/A
Volume22.00K
Average Volume (3M)227.59K
Market Cap
AU$18.96M
Enterprise ValueAU$22.36
Total Cash (Recent Filing)AU$2.52M
Total Debt (Recent Filing)AU$10.82M
Price to Earnings (P/E)―
Beta1.61
Next Earnings
Feb 23, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield6.27%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding428,428,220
10 Day Avg. Volume48,256
30 Day Avg. Volume227,589
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.70
Price to Sales (P/S)0.66
P/FCF Ratio-55.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.01
Revenue Forecast (FY)AU$32.00M
Bulls Say, Bears Say
Bulls Say
Revenue RecoveryThe recovery indicates improving demand for IDT’s contract development and manufacturing services. Sustained growth would improve factory utilization, spread fixed costs across more output, and strengthen the platform’s ability to support larger customer programs.
Positive Operating Cash FlowThe return to positive operating cash flow is a constructive operating inflection for a contract manufacturer. It suggests recent revenue activity is beginning to convert into cash, potentially reducing reliance on external funding if maintained across future reporting periods.
Meaningful Equity BaseA substantial equity base provides a financial buffer for regulated manufacturing operations and ongoing investment in facilities, quality systems, and capacity. Moderate leverage offers more resilience than a highly debt-funded structure, provided borrowings do not continue rising.
Bears Say
Persistent UnprofitabilityNegative net and operating margins show that the revenue recovery has not yet produced a sustainable economic return. Continued losses can restrict reinvestment, weaken negotiating flexibility with customers, and make the turnaround dependent on improved pricing, mix, or capacity utilization.
Weak Free Cash Flow ConversionPositive operating cash flow has not yet translated into positive free cash flow, indicating continuing reinvestment needs or working-capital volatility. Limited cash coverage of losses reduces the durability of the recovery and may constrain funding for manufacturing capabilities.
Rising Leverage And Negative ReturnsHigher leverage reduces financial flexibility while negative ROE indicates the equity base is not yet generating acceptable returns. Together, these factors increase execution risk and could limit IDT’s ability to absorb delays, cost overruns, or uneven customer volumes.
IDT Australia Limited News
IDT FAQ
What was IDT Australia Limited’s price range in the past 12 months?
IDT Australia Limited lowest share price was AU$0.03 and its highest was AU$0.07 in the past 12 months.
What is IDT Australia Limited’s market cap?
IDT Australia Limited’s market cap is AU$18.96M.
When is IDT Australia Limited’s upcoming earnings report date?
IDT Australia Limited’s upcoming earnings report date is Feb 23, 2027 which is in 169 days.
How were IDT Australia Limited’s earnings last quarter?
IDT Australia Limited released its earnings results on Aug 20, 2026. The company reported -AU$0.003 earnings per share for the quarter.
Is IDT Australia Limited overvalued?
According to Wall Street analysts IDT Australia Limited’s price is currently Overvalued.
Does IDT Australia Limited pay dividends?
IDT Australia Limited pays a Semiannually dividend of AU$0.008 which represents an annual dividend yield of 6.27%. See more information on IDT Australia Limited dividends here
What is IDT Australia Limited’s EPS estimate?
IDT Australia Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IDT Australia Limited have?
IDT Australia Limited has 428,428,220 shares outstanding.
What happened to IDT Australia Limited’s price movement after its last earnings report?
IDT Australia Limited reported an EPS of -AU$0.003 in its last earnings report. Following the earnings report the stock price went up 7.317%.
Which hedge fund is a major shareholder of IDT Australia Limited?
Currently, no hedge funds are holding shares in AU:IDT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IDT Australia Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IDT Sentiment 75%
Sector Average 60%
Sector Average 60%
Insider Transactions
Bought Shares
Worth AU$4.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-29.23%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-5.50%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
IDT Australia Limited
IDT Australia Limited is an enterprise deeply involved in the entire lifecycle of pharmaceutical products, from initial research and development through to manufacturing and global distribution of both active pharmaceutical ingredients (APIs) and finished dosage forms. The company furnishes comprehensive analytical support, including the establishment of testing methodologies, stability assessments utilizing specialized chambers, and quality control laboratory services for both chemical and microbiological applications. Furthermore, its service offerings span project management, chemical processing, advanced analytical chemistry, pharmacy support, clinical trial packaging, and regulatory compliance assistance, alongside pharmaceutical development expertise across diverse dosage forms. Notably, IDT Australia also provides medicinal cannabis products and a broad array of contract manufacturing solutions. Established in 1975, the firm is headquartered in Boronia, Australia.
Technical Analysis
Cann Group
―
Vita Life Sciences Limited
―
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―